Vagus nerve stimulation: indications and limitations
- PMID: 17691314
- DOI: 10.1007/978-3-211-33081-4_31
Vagus nerve stimulation: indications and limitations
Abstract
Vagus nerve stimulation (VNS) is an established treatment for selected patients with medically refractory seizures. Recent studies suggest that VNS could be potentially useful in the treatment of resistant depressive disorder. Although a surgical procedure is required in order to implant the VNS device, the possibility of a long-term benefit largely free of severe side effects could give VNS a privileged place in the management of resistant depression. In addition, VNS appears to affect pain perception in depressed adults; a possible role of VNS in the treatment of severe refractory headache, intractable chronic migraine and cluster headache has also been suggested. VNS is currently investigated in clinical studies, as a potential treatment for essential tremor, cognitive deficits in Alzheimer's disease, anxiety disorders, and bulimia. Finally, other studies explore the potential use of VNS in the treatment of resistant obesity, addictions, sleep disorders, narcolepsy, coma and memory and learning deficits.
Similar articles
-
Vagus nerve stimulation for epilepsy and depression.Neurotherapeutics. 2008 Jan;5(1):75-85. doi: 10.1016/j.nurt.2007.10.071. Neurotherapeutics. 2008. PMID: 18164486 Free PMC article. Review.
-
Beyond the treatment of epilepsy: new applications of vagus nerve stimulation in psychiatry.CNS Spectr. 2003 Jul;8(7):515-21. doi: 10.1017/s1092852900018988. CNS Spectr. 2003. PMID: 12894032 Review.
-
Vagus nerve stimulation relieves chronic refractory migraine and cluster headaches.Cephalalgia. 2005 Feb;25(2):82-6. doi: 10.1111/j.1468-2982.2005.00611.x. Cephalalgia. 2005. PMID: 15658944 Clinical Trial.
-
Vagus nerve stimulation affects pain perception in depressed adults.Pain Res Manag. 2005 Spring;10(1):9-14. doi: 10.1155/2005/256472. Pain Res Manag. 2005. PMID: 15782242
-
[Vagus nerve stimulation (VNS) in the treatment of drug-resistant epilepsy. A 4-year follow-up evaluation of VNS treatment efficacy].Neurol Neurochir Pol. 2003 May-Jun;37(3):573-86. Neurol Neurochir Pol. 2003. PMID: 14593753 Clinical Trial. Polish.
Cited by
-
Epilepsy monitoring units in Saudi Arabia: Where do we stand compared to developed countries?Neurosciences (Riyadh). 2018 Jul;23(3):244-249. doi: 10.17712/nsj.2018.3.20170412. Neurosciences (Riyadh). 2018. PMID: 30008001 Free PMC article.
-
Wake-promoting effects of vagus nerve stimulation after traumatic brain injury: upregulation of orexin-A and orexin receptor type 1 expression in the prefrontal cortex.Neural Regen Res. 2018 Feb;13(2):244-251. doi: 10.4103/1673-5374.226395. Neural Regen Res. 2018. PMID: 29557373 Free PMC article.
-
Vagus nerve stimulation in dementia: A scoping review of clinical and pre-clinical studies.AIMS Neurosci. 2024 Sep 27;11(3):398-420. doi: 10.3934/Neuroscience.2024024. eCollection 2024. AIMS Neurosci. 2024. PMID: 39431268 Free PMC article.
-
Vagus Nerve Stimulation: A Potential Adjunct Therapy for COVID-19.Front Med (Lausanne). 2021 May 7;8:625836. doi: 10.3389/fmed.2021.625836. eCollection 2021. Front Med (Lausanne). 2021. PMID: 34026778 Free PMC article.
-
Repeated ethanol exposure and withdrawal alters ACE2 expression in discrete brain regions: Implications for SARS-CoV-2 infection.bioRxiv [Preprint]. 2022 Mar 29:2022.03.29.486282. doi: 10.1101/2022.03.29.486282. bioRxiv. 2022. Update in: Alcohol Clin Exp Res (Hoboken). 2023 Feb;47(2):219-239. doi: 10.1111/acer.15000. PMID: 35378747 Free PMC article. Updated. Preprint.
Publication types
MeSH terms
LinkOut - more resources
Other Literature Sources
Medical